Japan oncology market overview: Current and future perspectives
Authors:
- 16 May 2019
- journal article
- review article
- Published by SAGE Publications in Journal of Generic Medicines
- Vol. 15 (3) , 104-114
Abstract
The anti-cancer drug market is considered a growth market in Japan and across the world. Pharmaceutical companies have made every effort to deliver innovative drugs in this field, boosting market growth. In their research and development of anti-cancer drugs, these pharmaceuticals need to identify the optimal drug modalities in order to maximize profit, as the drugs are divided into two groups: cytotoxic-based drugs and target-based drugs. Although there have been numerous studies focused on the critical role of molecular target cancer therapy in anti-cancer drug development in Japan and elsewhere, few studies have quantitatively assessed the Japanese market using actual prescription data. This article provides an overview of the anti-cancer drug market in Japan as a foundation for formulating a global business strategy. It identifies key characteristics of the Japanese anti-cancer drug market and offers a prognosis of the market based on study findings.Keywords
This publication has 56 references indexed in Scilit:
- Anticancer Drug Prescription Patterns in Japan: Future Directions in Cancer TherapyTherapeutic Innovation & Regulatory Science, 2018
- Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including JapanClinical Therapeutics, 2018
- A comprehensive map of molecular drug targetsNature Reviews Drug Discovery, 2016
- Evaluating the Effectiveness of Repricing for Market Expansion in the Japanese Drug Pricing SystemTherapeutic Innovation & Regulatory Science, 2016
- Comparative Analysis Between the Top-Selling Drugs in the Japanese Pharmaceutical Market and Those in the United States, the United Kingdom, France, and GermanyTherapeutic Innovation & Regulatory Science, 2016
- Impact of Premium Rewards for the Promotion of Innovative Drug Discovery on the Japanese Pharmaceutical Market: An Analysis by Therapeutic AreaTherapeutic Innovation & Regulatory Science, 2016
- Factors That Affect the Acquisition of Reward Premiums for Promotion of Innovative Drug Discovery in JapanTherapeutic Innovation & Regulatory Science, 2016
- Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) projectJapanese Journal of Clinical Oncology, 2015
- Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?International Journal of Clinical Oncology, 2015
- Regulatory review time for approval of oncology drugs in Japan between 2001 and 2014. Considerations of changes, factors that affect review time, and difference with the United StatesThe Journal of Clinical Pharmacology, 2015